DIPNA PHARMACHEM LIMITED : REAFFIRMS NO DEVIATION IN FUND UTILIZATION

• Company certified no deviation or variation in utilization of funds from preferential issue of Convertible Warrants during the half and year ended 31st March, 2026. • The utilization of funds for 'To Meet Working Capital Requirements' was ₹7497.71 L, modified to ₹5679.93 L, with a deviation of ₹1584.71 L. • For 'General Corporate Purpose', funds were ₹2499.24 L, modified to ₹1893.31 L, with a deviation of ₹528.24 L. • This declaration is in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Impact: Neutral (Procedural confirmation of fund utilization without material deviation reported)

Dipna Pharmachem Ltd

Open attachment

← Back to feed